Global Cephalosporin Drugs Market Forecast to 2027: Growing Research & Development Activities and Increasing Healthcare Awareness

DUBLIN, Feb. 21, 2018 /PRNewswire/ --

The "Global Cephalosporin Drugs Market Analysis & Trends - Industry Forecast to 2027" report has been added to's offering.

The Global Cephalosporin Drugs Market is poised for grow strong during the forecast period 2017 to 2027

Some of the prominent trends that the market is witnessing include rising incidence of diseases, growing research & development activities and increasing healthcare awareness.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategie for the existing players, new entrants and the future investors.

Report Highlights:

    --  The report provides a detailed analysis on current and future market
        trends to identify the investment opportunities
    --  Market forecasts till 2027, using estimated market values as the base
    --  Key market trends across the business segments, Regions and Countries
    --  Key developments and strategies observed in the market
    --  Market Dynamics such as Drivers, Restraints, Opportunities and other
    --  In-depth company profiles of key players and upcoming prominent players
    --  Growth prospects among the emerging nations through 2027
    --  Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline
1.1 Research Methodology
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Raising incidence of diseases
3.1.2 Growing research & development activities
3.1.3 Increasing healthcare awareness
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Cephalosporin Drugs Market, By Cable Type
4.1 Generics
4.2 Branded

5 Cephalosporin Drugs Market, By Route of Administration
5.1 Injectables
5.2 Oral

6 Cephalosporin Drugs Market, By Spectrum
6.1 Fifth Generation
6.2 Fourth Generation
6.3 Third Generation
6.4 Second Generation
6.5 First Generation

7 Cephalosporin Drugs Market, By Type of Treatment
7.1 First Line of Treatment Serious infections Meningitis Sexually transmitted infections Pelvic inflammatory disease Gonorrhoea Epididymo-orchitis
7.2 Second Line of Treatment Urinary tract infections in pregnancy Respiratory tract infections Sinusitis Otitis media Skin infections Mastitis Diabetic foot infections Cellulitis

8 Cephalosporin Drugs Market, By Geography

9 Key Player Activities
9.1 Mergers & Acquisitions
9.2 Partnerships, Joint Venture's, Collaborations and Agreements
9.3 Product Launch & Expansions
9.4 Other Activities

10 Leading Companies

    --  Abbott
    --  Allergan
    --  Aspen Pharmacare
    --  Astellas
    --  Basilea Pharmaceuticals
    --  Baxter
    --  Bristol-Myers Squibb
    --  Glaxo SmithKline
    --  Kyorin Pharmaceutical
    --  Lupin Pharmaceuticals
    --  Merck
    --  Pfizer
    --  Ranbaxy
    --  Roche
    --  Sandoz
    --  Teva Pharmaceuticals

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets